Entrada Therapeutics Inc (TRDA)

17.56 +0.10 (+0.57%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Entrada Therapeutics Free Cash Flow to Firm (Quarterly)

Free Cash Flow to Firm (Quarterly) Chart

View Free Cash Flow to Firm (Quarterly) for TRDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow to Firm (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow to the Firm Definition

View Free Cash Flow to the Firm Definition
Start Trial

Free cash flow to firm measures the total cash flow available after all expenses and investments. This metric can give a good idea of the health of a company's operations.

Read full definition.

Free Cash Flow to Firm (Quarterly) Range, Past 5 Years

View Free Cash Flow to Firm (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow to Firm (Quarterly) Benchmarks

View Free Cash Flow to Firm (Quarterly) Benchmarks
Start Trial
Catalyst Pharmaceuticals Inc Upgrade
Vertex Pharmaceuticals Inc Upgrade
Sarepta Therapeutics Inc Upgrade
Regenxbio Inc --
Edgewise Therapeutics Inc --

Free Cash Flow to Firm (Quarterly) Related Metrics

Cash from Operations (Quarterly) Upgrade
Cash from Investing (Quarterly) Upgrade
Cash from Financing (Quarterly) Upgrade
Free Cash Flow Upgrade
Free Cash Flow Per Share (Quarterly) Upgrade
Free Cash Flow to Equity (Quarterly) Upgrade
Free Cash Flow Yield Upgrade